3 ms·
The study's three authors retracted their study on June 4th, "because independent peer reviewers could not access the data used for the analysis," reports The H
by MilnerRoute 6y ago
The study's three authors retracted their study on June 4th, "because independent peer reviewers could not access the data used for the analysis," reports The Hill. "The source of the data was Surgisphere Corporation, which told peer reviewers it would not transfer the full dataset used for the study because it would violate client agreements and confidentiality requirements."
However, the same day the New England Journal of Medicine published results from a new double-blind randomized, placebo-controlled trial which found hydroxychloroquine didn't help prevent people exposed to others with Covid-19 from developing the disease. One of the study's co-authors said that as a preventative agent, "It doesn't seem to work."
https://science.slashdot.org/story/20/05/23/0140202/study-of-96000-covid-19-patients-finds-hydroxychloroquine-increased-their-risk-of-dying https://science.slashdot.org/story/20/05/23/0140202/study-of...
- mxcrossb 6y agoThis should terrify any researcher working with a private company’s data. I think top journals need to change their policy here ably data availability, especially when private companies get involved.
- WalterBright 6y ago> private companies Government entities hardly exempt from self-serving bias and manipulation.
- triyambakam 6y agoImportant distinction though - preventative vs curative